Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
New Nordic Healthbrands ABFRA:N9X -2.69%62 ROC (Joel Greenblatt) % is 33.17% as of Jun. 2026, which is 18% above its 10-year median of 28.17. GuruFocus rates FRA:N9X with a GF Score™ of 62/100 and a GF Value™ of €1.72. The stock has 3 warning signs investors should review. Among 1,975 Consumer Packaged Goods companies, New Nordic Healthbrands AB ranks better than 53.67% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. New Nordic Healthbrands AB's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2026 was 33.17%.
The historical rank and industry rank for New Nordic Healthbrands AB's ROC (Joel Greenblatt) % or its related term are showing as below:
FRA:N9X'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -4.27 Med: 28.17 Max: 64.37
Current: 13.34
During the past 13 years, New Nordic Healthbrands AB's highest ROC (Joel Greenblatt) % was 64.37%. The lowest was -4.27%. And the median was 28.17%.
FRA:N9X's ROC (Joel Greenblatt) % is ranked better than 53.67% of 1975
companies
in the Consumer Packaged Goods industry
Industry Median: 12.08
vs FRA:N9X: 13.34
New Nordic Healthbrands AB (FRA:N9X) ROC (Joel Greenblatt) % Explanation
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
New Nordic Healthbrands AB ROC (Joel Greenblatt) % Chart
FRA:N9X vs KHC, GIS, HRL: ROC (Joel Greenblatt) % Comparison
For the Packaged Foods subindustry, New Nordic Healthbrands AB's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
New Nordic Healthbrands AB ROC (Joel Greenblatt) % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, New Nordic Healthbrands AB's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where New Nordic Healthbrands AB's ROC (Joel Greenblatt) % falls into.
New Nordic Healthbrands AB ROC (Joel Greenblatt) % Calculation
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is four times the quarterly (Jun. 2026) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 33.17% mean?
New Nordic Healthbrands AB (FRA:N9X) has a ROC (Joel Greenblatt) % of 33.17% as of Jun. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on New Nordic Healthbrands AB and its competitors. This is 18% above median its historical median of 28.17. According to the industry distribution chart, New Nordic Healthbrands AB ranks #915 out of 1975 companies in the Consumer Packaged Goods industry, placing it in the top 46.3%.
Is New Nordic Healthbrands AB's ROC (Joel Greenblatt) % too high?
New Nordic Healthbrands AB's current ROC (Joel Greenblatt) % of 33.17% is 18% above median its 10-year median of 28.17. The Consumer Packaged Goods industry median ROC (Joel Greenblatt) % is 12.08. New Nordic Healthbrands AB's value of 33.17% is 174.6% above this industry median. Based on the distribution chart, New Nordic Healthbrands AB ranks #915 out of 1975 companies in the Consumer Packaged Goods industry, which is above the industry midpoint. Overall, New Nordic Healthbrands AB has a GF Score™ of 62/100, reflecting its overall financial health beyond just this single metric.
How does New Nordic Healthbrands AB's ROC (Joel Greenblatt) % compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, New Nordic Healthbrands AB ranks #915 out of 1975 companies for ROC (Joel Greenblatt) %. This puts New Nordic Healthbrands AB in the upper half of its industry. The industry median ROC (Joel Greenblatt) % is 12.08. New Nordic Healthbrands AB's value of 33.17% is 174.6% above this benchmark. While the company's 10-year median is 28.17 vs. the industry median of 12.08, New Nordic Healthbrands AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Consumer Packaged Goods company?
The median ROC (Joel Greenblatt) % among Consumer Packaged Goods companies is 12.08, based on 1,975 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. New Nordic Healthbrands AB's current ROC (Joel Greenblatt) % of 33.17% is 174.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on New Nordic Healthbrands AB and its competitors. For the Consumer Packaged Goods industry, the median ROC (Joel Greenblatt) % is 12.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. New Nordic Healthbrands AB's current ROC (Joel Greenblatt) % is 33.17%, which is 18% above median its own 10-year median of 28.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is New Nordic Healthbrands AB stock overvalued right now?
New Nordic Healthbrands AB (FRA:N9X) has a current ROC (Joel Greenblatt) % of 33.17%. The stock's GF Value™ is €1.72, compared to a current price of €1.63 — trading 5.5% below its estimated fair value. The current ROC (Joel Greenblatt) % is 33.17%, which is 18% above median its 10-year median of 28.17 and 174.6% above the Consumer Packaged Goods industry median of 12.08. New Nordic Healthbrands AB's overall GF Score™ is 62/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For New Nordic Healthbrands AB (FRA:N9X), the current ROC (Joel Greenblatt) % is 33.17% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is New Nordic Healthbrands AB (FRA:N9X) Overvalued in 2026?
Based on GuruFocus' analysis, New Nordic Healthbrands AB stock appears to be undervalued.
The current stock price of €1.63 is trading 5.5% below its estimated GF Value™ of €1.72.
Key valuation signals for FRA:N9X:
ROC (Joel Greenblatt) %: 33.17% (18% above median its 10-year median of 28.17)
GF Value™: €1.72 vs. price of €1.63 (5.5% below fair value)
Industry Position: 174.6% above the Consumer Packaged Goods median (#915 of 1975)
No single metric tells the full story. See the FRA:N9X stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
New Nordic Healthbrands AB develops herbal supplements, herbal remedies, and personal care products to satisfy specific health and beauty needs. The products are sold in North America, Europe, and Asia. Some products sold are Active legs, Active Liver, Apple Cider, Chili Burn, Clear brain, Ear tone, Equazen, Frutin gastro gel, Hair Gro, Hair Volume, Kilo trim, and Melissa Dream. Maximum revenue is generated from the Nordic region.
62GF Score
Get the complete analysis for FRA:N9X
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:N9X has been successfully added to your 
